MDMA for Co-occurring PTSD and OUD After Childbirth
MDMA-Assisted Therapy 6 to 12 Months After Childbirth for People With Co-occurring Opioid Use and Post Traumatic Stress Disorders
Sponsor: Multidisciplinary Association for Psychedelic Studies
This PHASE2 trial investigates Opioid Use Disorder and Stress Disorders, Post-Traumatic and is currently actively recruiting participants. Multidisciplinary Association for Psychedelic Studies leads this study, which shows 12 recorded versions since 2024 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Apr 2025 — Present [monthly]
Recruiting PHASE2
Status: Active Not Recruiting → Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Not Yet Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Mar 2024 — Jun 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2024 — Mar 2024 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2023 — Jan 2024 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2023 — Oct 2023 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2023 — Jun 2023 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Multidisciplinary Association for Psychedelic Studies
- University of New Mexico
For direct contact, visit the study record on ClinicalTrials.gov .